USD
GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine. That identity is more specific than the broad phrase “copper peptide.” Researchers should distinguish free GHK, copper-complexed GHK-Cu and modified derivatives before comparing literature or catalog listings.
- GHK is a tripeptide; GHK-Cu is its copper complex.
- Copper state and chemical form belong in the identity record.
- Topical formulation findings do not automatically validate every GHK-Cu material or route.
GHK, GHK-Cu and related labels
| Label | Meaning | Catalog question |
|---|---|---|
| GHK | Gly-His-Lys tripeptide | Is copper absent or simply unstated? |
| GHK-Cu | Copper(II) complex of GHK | What chemical form and documentation are supplied? |
| Modified GHK | GHK with another chemical modification | Which modification and sequence are present? |
The distinction matters because copper complexation can change physicochemical behavior. A paper studying free GHK, a topical formulation or a nanofiber-bound copper complex is not automatically evidence for every GHK-Cu catalog material.
What researchers should record
- Full name: glycyl-L-histidyl-L-lysine copper complex.
- Sequence or condensed identity when available.
- Copper-complex status and counterion or chemical form.
- Listed mass per vial and vial count.
- Lot-specific identity and analytical methods, if supplied.
The NOVABIO CU100 GHK-Cu listing spells out the long-form peptide name. It sits within Repair & Structural Research, where researchers can compare it with single compounds and blends. If GHK-Cu appears in a multi-component listing, the total blend strength should not be treated as the GHK-Cu component strength unless an allocation is shown.
How to interpret the literature
Published reviews discuss GHK and GHK-Cu in tissue-remodeling and topical-formulation research. They also identify gaps, including limited clinical data for some promoted uses and formulation-dependent permeability. A careful summary names the model and formulation rather than reducing the evidence to “GHK-Cu works.”
Use NOVABIO’s product-title guide to separate identity, strength and quantity. For documentation questions, use Contact Us.
Frequently asked questions
What is GHK-Cu?
GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine, a three-amino-acid peptide abbreviated GHK. The copper state is part of the material identity. Free GHK, GHK-Cu and chemically modified GHK derivatives should not be treated as interchangeable without matching documentation.
Is GHK-Cu the same as every copper peptide?
No. “Copper peptide” is a broad description, while GHK-Cu identifies a specific tripeptide-copper complex. Other peptides can bind copper, and GHK may also appear without copper or with additional modifications. Researchers should use the exact sequence and chemical form when comparing products or papers.
What should a GHK-Cu product record include?
Record the full name, sequence, copper-complex status, chemical form, listed mass per vial, vial count, SKU and lot documentation. If the material is part of a blend, capture the stated component allocation rather than assuming the total blend mass belongs entirely to GHK-Cu.
Sources
- PubMed: GHK and tissue remodeling (accessed 2026-08-27)
- PubMed: topical GHK evidence and limitations (accessed 2026-08-27)
- PubMed: peptide reference standards (accessed 2026-08-27)
Research-use notice: This article explains catalog identity and published research. It is not medical advice, a treatment claim or a dosing guide. NOVABIO catalog products are presented for laboratory research and are not represented here as approved for human use.